CARsgen Therapeutics
CARsgen US is a biopharmaceutical company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.

Year Established: 2014
Stock Ticker:
Exchange:
CARsgen US is a biopharmaceutical company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.
CARsgen US is a biopharmaceutical company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.
CARsgen US is a biopharmaceutical company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors.